Familial antiphospholipid antibodies and acquired circulating anticoagulants

I. ElHajj, I. Uthman, A. Chahel, F. Khoury, Thurayya Arayssi, Ali Taher

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Familial clustering of elevated antiphospholipid antibody levels has been described, but the reports are heterogeneous with regard to the characterization of the antiphospholipid syndrome (APS), coexisting autoimmune diseases and clinical implications. We report a familial occurrence of APS in two patients, in the presence of SLE in the mother and absence of autoimmune diseases in the daughter along with acquired circulating inhibitors in both cases: platelet inhibitor and factor IX inhibitor, respectively.

Original languageEnglish
Pages (from-to)812-814
Number of pages3
JournalLupus
Volume13
Issue number10
DOIs
Publication statusPublished - 2004
Externally publishedYes

Fingerprint

Antiphospholipid Antibodies
Autoimmune Diseases
Factor IX
Antiphospholipid Syndrome
Platelet Aggregation Inhibitors
Nuclear Family
Cluster Analysis
Mothers
circulating anticoagulants
Familial antiphospholipid syndrome

Keywords

  • Factor IX inhibitor
  • Familial antiphospholipid syndrome
  • Platelet inhibitor
  • Prolonged bleeding time

ASJC Scopus subject areas

  • Rheumatology
  • Immunology

Cite this

Familial antiphospholipid antibodies and acquired circulating anticoagulants. / ElHajj, I.; Uthman, I.; Chahel, A.; Khoury, F.; Arayssi, Thurayya; Taher, Ali.

In: Lupus, Vol. 13, No. 10, 2004, p. 812-814.

Research output: Contribution to journalArticle

ElHajj, I, Uthman, I, Chahel, A, Khoury, F, Arayssi, T & Taher, A 2004, 'Familial antiphospholipid antibodies and acquired circulating anticoagulants', Lupus, vol. 13, no. 10, pp. 812-814. https://doi.org/10.1191/0961203303lu1059cr
ElHajj, I. ; Uthman, I. ; Chahel, A. ; Khoury, F. ; Arayssi, Thurayya ; Taher, Ali. / Familial antiphospholipid antibodies and acquired circulating anticoagulants. In: Lupus. 2004 ; Vol. 13, No. 10. pp. 812-814.
@article{f798f9ae1c854341898d5fb91ef56805,
title = "Familial antiphospholipid antibodies and acquired circulating anticoagulants",
abstract = "Familial clustering of elevated antiphospholipid antibody levels has been described, but the reports are heterogeneous with regard to the characterization of the antiphospholipid syndrome (APS), coexisting autoimmune diseases and clinical implications. We report a familial occurrence of APS in two patients, in the presence of SLE in the mother and absence of autoimmune diseases in the daughter along with acquired circulating inhibitors in both cases: platelet inhibitor and factor IX inhibitor, respectively.",
keywords = "Factor IX inhibitor, Familial antiphospholipid syndrome, Platelet inhibitor, Prolonged bleeding time",
author = "I. ElHajj and I. Uthman and A. Chahel and F. Khoury and Thurayya Arayssi and Ali Taher",
year = "2004",
doi = "10.1191/0961203303lu1059cr",
language = "English",
volume = "13",
pages = "812--814",
journal = "Lupus",
issn = "0961-2033",
publisher = "SAGE Publications Ltd",
number = "10",

}

TY - JOUR

T1 - Familial antiphospholipid antibodies and acquired circulating anticoagulants

AU - ElHajj, I.

AU - Uthman, I.

AU - Chahel, A.

AU - Khoury, F.

AU - Arayssi, Thurayya

AU - Taher, Ali

PY - 2004

Y1 - 2004

N2 - Familial clustering of elevated antiphospholipid antibody levels has been described, but the reports are heterogeneous with regard to the characterization of the antiphospholipid syndrome (APS), coexisting autoimmune diseases and clinical implications. We report a familial occurrence of APS in two patients, in the presence of SLE in the mother and absence of autoimmune diseases in the daughter along with acquired circulating inhibitors in both cases: platelet inhibitor and factor IX inhibitor, respectively.

AB - Familial clustering of elevated antiphospholipid antibody levels has been described, but the reports are heterogeneous with regard to the characterization of the antiphospholipid syndrome (APS), coexisting autoimmune diseases and clinical implications. We report a familial occurrence of APS in two patients, in the presence of SLE in the mother and absence of autoimmune diseases in the daughter along with acquired circulating inhibitors in both cases: platelet inhibitor and factor IX inhibitor, respectively.

KW - Factor IX inhibitor

KW - Familial antiphospholipid syndrome

KW - Platelet inhibitor

KW - Prolonged bleeding time

UR - http://www.scopus.com/inward/record.url?scp=7644243106&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=7644243106&partnerID=8YFLogxK

U2 - 10.1191/0961203303lu1059cr

DO - 10.1191/0961203303lu1059cr

M3 - Article

VL - 13

SP - 812

EP - 814

JO - Lupus

JF - Lupus

SN - 0961-2033

IS - 10

ER -